BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25048529)

  • 1. Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery.
    Huang AJ; Huang KE; Page BR; Ayala-Peacock DN; Lucas JT; Lesser GJ; Laxton AW; Tatter SB; Chan MD
    J Neurooncol; 2014 Oct; 120(1):163-9. PubMed ID: 25048529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases.
    Atalar B; Modlin LA; Choi CY; Adler JR; Gibbs IC; Chang SD; Harsh GR; Li G; Nagpal S; Hanlon A; Soltys SG
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):713-8. PubMed ID: 24054875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery.
    Johnson MD; Avkshtol V; Baschnagel AM; Meyer K; Ye H; Grills IS; Chen PY; Maitz A; Olson RE; Pieper DR; Krauss DJ
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):537-43. PubMed ID: 26867883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic radiosurgery for focal leptomeningeal disease in patients with brain metastases.
    Wolf A; Donahue B; Silverman JS; Chachoua A; Lee JK; Kondziolka D
    J Neurooncol; 2017 Aug; 134(1):139-143. PubMed ID: 28536993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptomeningeal disease following stereotactic radiosurgery for brain metastases from breast cancer.
    Trifiletti DM; Romano KD; Xu Z; Reardon KA; Sheehan J
    J Neurooncol; 2015 Sep; 124(3):421-7. PubMed ID: 26093620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery.
    Siomin VE; Vogelbaum MA; Kanner AA; Lee SY; Suh JH; Barnett GH
    J Neurooncol; 2004; 67(1-2):115-21. PubMed ID: 15072456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast brain metastases are associated with increased risk of leptomeningeal disease after stereotactic radiosurgery: a systematic review and meta-analysis.
    Brown DA; Lu VM; Himes BT; Burns TC; Quiñones-Hinojosa A; Chaichana KL; Parney IF
    Clin Exp Metastasis; 2020 Apr; 37(2):341-352. PubMed ID: 31950392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic Radiosurgery for Resected Brain Metastases: Single-Institutional Experience of Over 500 Cavities.
    Shi S; Sandhu N; Jin MC; Wang E; Jaoude JA; Schofield K; Zhang C; Liu E; Gibbs IC; Hancock SL; Chang SD; Li G; Hayden-Gephart M; Adler JR; Soltys SG; Pollom EL
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):764-771. PubMed ID: 31785338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis.
    Suki D; Hatiboglu MA; Patel AJ; Weinberg JS; Groves MD; Mahajan A; Sawaya R
    Neurosurgery; 2009 Apr; 64(4):664-74; discussion 674-6. PubMed ID: 19197219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorrhagic and Cystic Brain Metastases Are Associated With an Increased Risk of Leptomeningeal Dissemination After Surgical Resection and Adjuvant Stereotactic Radiosurgery.
    Press RH; Zhang C; Chowdhary M; Prabhu RS; Ferris MJ; Xu KM; Olson JJ; Eaton BR; Shu HG; Curran WJ; Crocker IR; Patel KR
    Neurosurgery; 2019 Nov; 85(5):632-641. PubMed ID: 30335175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases.
    Prabhu RS; Turner BE; Asher AL; Marcrom SR; Fiveash JB; Foreman PM; Press RH; Patel KR; Curran WJ; Breen WG; Brown PD; Jethwa KR; Grills IS; Arden JD; Foster LM; Manning MA; Stern JD; Soltys SG; Burri SH
    Neuro Oncol; 2019 Aug; 21(8):1049-1059. PubMed ID: 30828727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone.
    Patel KR; Prabhu RS; Kandula S; Oliver DE; Kim S; Hadjipanayis C; Olson JJ; Oyesiku N; Curran WJ; Khan MK; Shu HK; Crocker I
    J Neurooncol; 2014 Dec; 120(3):657-63. PubMed ID: 25189789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases.
    Minniti G; Lanzetta G; Capone L; Giraffa M; Russo I; Cicone F; Bozzao A; Alongi F; Nicosia L; Fineschi G; Marchetti L; Tufo T; Bianciardi F; Esposito V; Gentile P; Paolini S
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34949695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis.
    Patel KR; Burri SH; Boselli D; Symanowski JT; Asher AL; Sumrall A; Fraser RW; Press RH; Zhong J; Cassidy RJ; Olson JJ; Curran WJ; Shu HG; Crocker IR; Prabhu RS
    J Neurooncol; 2017 Feb; 131(3):611-618. PubMed ID: 28000105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa.
    Suki D; Abouassi H; Patel AJ; Sawaya R; Weinberg JS; Groves MD
    J Neurosurg; 2008 Feb; 108(2):248-57. PubMed ID: 18240919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery.
    Ma R; Levy M; Gui B; Lu SE; Narra V; Goyal S; Danish S; Hanft S; Khan AJ; Malhotra J; Motwani S; Jabbour SK
    J Neurooncol; 2018 Jan; 136(2):395-401. PubMed ID: 29159778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
    Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
    J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative stereotactic radiosurgery before planned resection of brain metastases: updated analysis of efficacy and toxicity of a novel treatment paradigm.
    Prabhu RS; Miller KR; Asher AL; Heinzerling JH; Moeller BJ; Lankford SP; McCammon RJ; Fasola CE; Patel KR; Press RH; Sumrall AL; Ward MC; Burri SH
    J Neurosurg; 2018 Dec; 131(5):1387-1394. PubMed ID: 30554174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.